Consumer Health

Eye health is experiencing another year of double-digit current value growth in 2023, albeit at a marginally slower rate than 2022. Nevertheless, overall demand continues to rise. While there are no lockdown restrictions in place, the pandemic has…

Herbal/traditional products is experiencing another year of double-digit current value growth in 2023. Ingredient-led purchases are becoming increasingly common among local consumers, not only due to growing awareness of the benefits of certain…

Demand for NRT smoking cessation aids is declining in 2023, despite a further drop in smoking prevalence among the adult population as consumers continue to focus on their health post-pandemic. A marginal decline in retail volume sales is likely to…

Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…

Current value sales of sleep aids continue to rise in 2023, albeit at a slower rate due to stocking up and strong sales over the last three years since the emergence of the pandemic. Local consumers continue to experience the cost-of-living crisis in…

After a marginal decline in the first year of the pandemic, sports nutrition in the UK continues to record strong current value sales growth in 2023, following a full recovery in 2021. Apart from the price hikes driven by inflation since the end of…

Value sales of vitamins have rebounded in 2023, recording growth for the first time since 2021. Although value growth is much weaker than at the height of the pandemic, and overall retail volume sales are continuing to decline, demand remains above…

Weight management and wellbeing continues to experience strong value growth in 2023, as the general health and wellness trend remains prevalent post-pandemic. As consumers have returned to hectic routines with the reopening of offices, balancing a…

With a lack of new product development and brand activity in 2023, demand for wound care is being primarily driven by a full year without lockdown restrictions boosting out-of-home activities. The category’s performance is largely dependent on…

Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…

Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…

Value sales of analgesics in France continue to record solid growth in 2023 following a dynamic performance the previous year. The key growth driver is the increasing demand for acetaminophen, with the brand Doliprane from Sanofi, convincingly…

Upon the lifting of all COVID-19 related regulations, including the compulsory use of face masks, social distancing rules and compulsory self-isolation, there has been a surge in illness which has been a major contributor to sales growth for…

Analgesics sales are returning to more normal patterns in 2023, following the fluctuations caused by the COVID-19 pandemic and the sharp price rises seen in 2022. On balance, current value growth rates are still elevated compared to pre-pandemic…

Analgesics is expected to see a single-digit growth in current value terms in 2023. Sales are benefiting from the stable demand for analgesics and unit price increases linked to rising price lists as a result of the higher cost of production faced by…

Per capita consumption of analgesics continued to increase in Norway during 2023 after 2022 saw significant increases in consumption of these products. While there was some stockpiling of analgesics seen in Norway during the early stages of the…

While most categories of analgesics are set to witness decreases in retail volume sales over 2023, this is largely due to spikes in sales in the wake of the Coronavirus (COVID-19) pandemic as stress and anxiety levels increased. In 2023, many…

Consumer health in Belgium continues to see steady growth in current value terms in 2023, albeit at a slightly slower pace than in the previous year. Among the most dynamic categories are analgesics, sleep aids (driven by high stress levels among the…

Consumer health in Denmark is registering solid current value growth in 2023, albeit at a slightly slower rate than seen in the latter half of the review period; however, this growth is partly driven by strong inflation, which has resulted in price…

Consumer health in France continues to experience growth in 2023. Due to the pandemic, consumers’ immune systems have been negatively impacted. The French healthcare system remains weak and 2022 and 2023 have faced multiple challenges, including a…